

Most Read This Week
- COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced RCC
- Dr. Petros Grivas on Switching Jobs: Part 1
- Age-Based Outcomes in Patients With mRCC Treated With First-Line Targeted Therapy or Checkpoint Immunotherapy
- Dr. Petros Grivas on Switching Jobs: Part 2
- Management of Rare RCC Subtypes - Renal Medullary Carcinoma
Recently Updated
- 18F-PSMA-1007 PET/CT for Response Assessment in Patients With mRCC Undergoing Systemic Therapy
- Obesity Diminishes Response to PD-1–Based Immunotherapies in Renal Cancer
- Management of Rare RCC Subtypes - Renal Medullary Carcinoma
- Modified Glasgow Prognostic Score as a Predictor of Prognosis in mRCC Treated With Nivolumab
- No Association Between Race and 5-Year Survival in Patients With ccRCC